New Trials metric counts the total number of new subscriptions that started with a free trial period over a specific time period.
With Databox you can track all your metrics from various data sources in one place.
Used to show a simple Metric or to draw attention to one key number.
Databox is a business analytics software that allows you to track and visualize your most important metrics from any data source in one centralized platform.
To track New Trials using Databox, follow these steps:
Monitor key revenue metrics like MRR, ARR, and churn with live data from Stripe. Built for SaaS leaders, revenue teams, and growth strategists to drive smarter decisions.
Successful Charges metric measures the total number of completed transactions that were successfully charged using Stripe's payment processing system.
New Customers metric represents the number of unique customers who have made their first payment or transaction with your business within a given time period.
ARR (excl. Canceled Subscriptions) by Plan Name is a metric that calculates the total Annual Recurring Revenue generated by each subscription plan excluding canceled subscriptions, providing insights into which plans are driving the most revenue for a business.
New ARR (Annual Recurring Revenue) is a measure of the total new revenue earned in a given period through new customer acquisitions or upgrades in pricing or plans.
Active Subscriptions by Plan Name metric shows the total number of current active or past due subscriptions on a specific plan. It helps monitor the popularity of different subscription plans.
New Subscriptions (incl. Trials) by Plan Name metric measures the number of new subscriptions including Trials created for each plan in a given time frame, providing insights into the performance and popularity of different subscription plans.
The Downgrades metric measures the number of customers who have shifted from a higher-priced subscription plan to a lower-priced one within a specified timeframe.
Trial Conversion Rate measures success in converting trials to active subscriptions over a rolling 30-day period, excluding today.